Apogee Therapeutics (APGE) Long-Term Investments (2024 - 2026)
Apogee Therapeutics (APGE) reported Long-Term Investments of $198.4 million for Q1 2026, up 17.99% year-over-year from $168.1 million in Q1 2025, and up 14.83% on a QoQ basis from $172.7 million in Q4 2025.
Apogee Therapeutics (APGE) has 3 years of Long-Term Investments data on file, last reported at $198.4 million in Q1 2026.
- Quarterly Long-Term Investments rose 17.99% year-over-year to $198.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.4 million (up 17.99% YoY) and the FY2025 annual result came in at $172.7 million, down 17.91% from the prior year.
- Long-Term Investments improved to $198.4 million in Q1 2026 per APGE's latest filing, from $172.7 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $227.7 million in Q3 2024 and bottomed at $61.6 million in Q3 2025.
- The 3-year median for Long-Term Investments is $170.4 million (2025), against an average of $158.5 million.
- The widest annual swing landed in 2025, when Long-Term Investments sank 72.95%; it then rose 17.99% in 2026.
- Tracing APGE's Long-Term Investments over 3 years: stood at $210.4 million in 2024, then fell by 17.91% to $172.7 million in 2025, then grew by 14.83% to $198.4 million in 2026.
- Per Business Quant, the three latest APGE Long-Term Investments figures stand at $198.4 million (Q1 2026), $172.7 million (Q4 2025), and $61.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 198.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198.35 Mn |
| Dec 31, 2025 | 172.73 Mn |
| Sep 30, 2025 | 61.60 Mn |
| Jun 30, 2025 | 115.80 Mn |
| Mar 31, 2025 | 168.11 Mn |
| Dec 31, 2024 | 210.42 Mn |
| Sep 30, 2024 | 227.75 Mn |
| Jun 30, 2024 | 113.40 Mn |